You searched for "Suturing"
Does vicryl stand the test of time?
This retrospective study aimed to assess whether the long-term success of ptosis surgery was influenced by use of absorbable or non-absorbable sutures. Four hundred and fifty-five operations in 330 patients met the inclusion criteria. One hundred and sixty-nine operations were...High score
Louie: “Allow me to present Pac-Man. Now, who is going to be the lucky pup who gets to play the first game? Iggy! You’re a somewhat compulsive personality. Step forward. Now… you see there’s the maze.” Iggy: “Uh-huh” Louie: “All...Sight Scotland and Sight Scotland Veterans appoint Paul Bott as new Chair of the Board
Sight Scotland and Sight Scotland Veterans are delighted to announce the appointment of Paul Bott as the new Chair of the Board.Clinical Council for Eye Health Commissioning elects Dr Gillian Rudduck MCOptom as Chair
Dr Gillian Rudduck MCOptom, President of The College of Optometrists, has been elected as the new chair of the Clinical Council for Eye Health Commissioning (CCEHC) following a vote by the members of the Council. The CCEHC is an independent...Ophthalmology elective in China
Wandering through the bustling streets of Zhejiang, China, immersed in the harmonious blend of modernity and tradition, I made my way to the Eye Centre of the Second Affiliated Hospital, Zhejiang University College of Medicine. The aroma of traditional Chinese...Hanson Wade: Dry AMD and Geographic Atrophy Therapeutics Summit 2025
Welcome to the 6th Dry AMD and Geographic Atrophy Therapeutics SummitTransformative Therapies for Dry, Intermediate & Late-Stage AMDWith late-phase trials advancing, novel mechanisms emerging, and global regulatory expectations evolving, the dry AMD and GA field is accelerating exponentially. Returning digitally...Andy Hill (NuVision Biotherapies) discusses recent AOP update to clinical guidelines
There are currently 600,000 people on the NHS waiting list for ophthalmology treatment, and over 5 million people in the UK currently live with dry eye disease. Here Andy Hill, CEO at NuVision Biotherapies Ltd, discusses a recent update to clinical guidelines and what this means for optometrists, patients, and taxpayers.
